Fraedrich G, Hofmann D, Effenhauser P, Jander R
Thorac Cardiovasc Surg. 1982 Feb;30(1):36-8. doi: 10.1055/s-2007-1022203.
Acute pleural empyema which is not amenable to pleural puncture or closed thoracic drainage should be treated operatively by decortication or, in persistent cavities, by open thoracostomy drainage. In the last 2 years we have instilled 500,000 IU of fibrinolysines (streptokinase and streptodornase) per day into the pleural cavity of 27 patients with pleural infections requiring closed intrapleural drainage. By means of this treatment, pus and fibrinous membranes are liquefied and necrotic tissue is discharge. Therapeutic success is indicated by considerably increased fluid drainage about one hour after instillation. This therapy was performed for an average of 5 days. In 12 patients (44%) pleural empyema could be cured. In the other 15 cases decortication, and in 3 of them open thoracostomy drainage, was necessary. In our opinion intrapleural instillation of fibrinolytic enzymes should be added to the well-recognized method of treatment of pleural empyema, although not replace them.
对于不宜进行胸腔穿刺或闭式胸腔引流的急性脓胸,应通过剥脱术进行手术治疗;对于持续存在的脓腔,则应通过开放胸廓造口引流。在过去两年中,我们每天向27例需要闭式胸腔内引流的胸膜感染患者的胸腔内注入50万国际单位的纤维蛋白溶解酶(链激酶和链道酶)。通过这种治疗,脓液和纤维蛋白膜被液化,坏死组织得以排出。滴注后约1小时引流液显著增加表明治疗成功。该治疗平均进行5天。12例患者(44%)的脓胸得以治愈。在其他15例患者中,需要进行剥脱术,其中3例需要开放胸廓造口引流。我们认为,尽管胸膜腔内注入纤维蛋白溶解酶不能替代公认的脓胸治疗方法,但应将其添加到这些方法中。